Ovid

Initiated collaboration with Graviton Bioscience to develop…

Collaboration to unlock the therapeutic potential of ROCK2…

Preclinical data demonstrate potential efficacy and safety of OV329 at low, chronic dosing, suggesting an improved profile compared to other GABA-aminotransferase inhibitors Data from the NIH/NINDs Epilepsy Therapy Screening Program…